ReviewFuture oncology (London, England)2024

Using bioinformatics and artificial intelligence to map the cyclin-dependent kinase 4/6 inhibitor biomarker landscape in breast cancer.

Kim Wager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.